ChromaDex Looks Interesting, But Highly Speculative
- ChromaDex is looking to the huge world of phytochemicals to find high-potential ingredients for supplements and nutritional products.
- Current products include a caffeine-pterostilbene formulation that delivers more caffeine to the bloodstream and a next-gen version of niacian that doesn't produce flushing.
- ChromaDex's share count has risen considerably over the years and the company needs money again. The valuation seems high at over 12x sales, but the basic business model seems reasonable.